Search research articles
Contact Us
Filters
Showing results (221-230 of 315) with videos related to
Page
of 32
Sort By:
Chest
|
August 5, 2021
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report
Scott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
Chest
|
August 5, 2021
Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report
Scott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 8, 2009
Multisociety task force recommendations of competencies in Pulmonary and Critical Care Medicine
John D Buckley, Doreen J Addrizzo-Harris, Alison S Clay, et al.
Circulation
|
November 23, 2005
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Harvey D White, Philip E G Aylward, Zhen Huang, et al.
Journal of Biotechnology
|
March 17, 2021
Biocompatibility of a nanocomposite based on Aerosil 380 and carboxylated fullerene C<sub>60</sub>[C(COOH)<sub>2</sub>]<sub>3</sub>
Vladimir V Sharoyko, Gleb O Iurev, Viktor N Postnov, et al.
Cell
|
February 28, 2015
Mechanism of human antibody-mediated neutralization of Marburg virus
Andrew I Flyak, Philipp A Ilinykh, Charles D Murin, et al.
Cell Reports
|
April 14, 2021
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
Charles D Murin, Pavlo Gilchuk, Philipp A Ilinykh, et al.
BMC Medicine
|
May 26, 2020
Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus
Susan Young, Jack Hollingdale, Michael Absoud, et al.
European Journal of Heart Failure
|
May 28, 2019
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
Chris J Kapelios, Mitja Lainscak, Gianluigi Savarese, et al.
The Journal of Physical Chemistry Letters
|
September 3, 2025
Physicochemical Properties of a Water-Soluble Adduct of C<sub>60</sub> with l-Cysteine for Biomedical Applications
Konstantin N Semenov, Ali Mlhem, Alexander V Akentiev, et al.
Page
of 32
Search research articles
Search
Showing results (221-230 of 315) with videos related to
Sort By:
Page
of 32
Chest
|
August 5, 2021
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report
Scott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
Chest
|
August 5, 2021
Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report
Scott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 8, 2009
Multisociety task force recommendations of competencies in Pulmonary and Critical Care Medicine
John D Buckley, Doreen J Addrizzo-Harris, Alison S Clay, et al.
Circulation
|
November 23, 2005
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Harvey D White, Philip E G Aylward, Zhen Huang, et al.
Journal of Biotechnology
|
March 17, 2021
Biocompatibility of a nanocomposite based on Aerosil 380 and carboxylated fullerene C<sub>60</sub>[C(COOH)<sub>2</sub>]<sub>3</sub>
Vladimir V Sharoyko, Gleb O Iurev, Viktor N Postnov, et al.
Cell
|
February 28, 2015
Mechanism of human antibody-mediated neutralization of Marburg virus
Andrew I Flyak, Philipp A Ilinykh, Charles D Murin, et al.
Cell Reports
|
April 14, 2021
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
Charles D Murin, Pavlo Gilchuk, Philipp A Ilinykh, et al.
BMC Medicine
|
May 26, 2020
Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus
Susan Young, Jack Hollingdale, Michael Absoud, et al.
European Journal of Heart Failure
|
May 28, 2019
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
Chris J Kapelios, Mitja Lainscak, Gianluigi Savarese, et al.
The Journal of Physical Chemistry Letters
|
September 3, 2025
Physicochemical Properties of a Water-Soluble Adduct of C<sub>60</sub> with l-Cysteine for Biomedical Applications
Konstantin N Semenov, Ali Mlhem, Alexander V Akentiev, et al.
Page
of 32